Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.1 has been added to the page. Older non-core revision notes (v3.4.0) and non-essential items such as the 'Multiple myeloma' topic and related topics, plus the funding-status notice, were removed.SummaryDifference0.6%

- Check9 days agoChange DetectedA site-wide funding notice about government operations and links to related topics (Multiple Myeloma and MedlinePlus Genetics) were added to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check16 days agoChange DetectedThe changes are minor UI and metadata adjustments on the study page, including adding 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', and removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check23 days agoChange DetectedA new site revision (v3.3.4) is shown, and older related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page.SummaryDifference0.2%

- Check44 days agoChange DetectedRemoved related topics including 'Multiple myeloma' and MedlinePlus Genetics from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.